Showing 3451-3460 of 18631 results for "".
Optimizing Barostim Outcomes: Practical Approaches to Patient Selection and Monitoring
https://reachmd.com/programs/cme/optimizing-barostim-outcomes-practical-approaches-to-patient-selection-and-monitoring/29819/Explore best practices for talking to patients about their QoL and successfully identifying appropriate candidates for treatment with Barostim.An Overview of Topical Therapies for Managing Pediatric AD
https://practicaldermatology.com/topics/atopic-dermatitis/an-overview-of-topical-ththerapies-for-managing-pediatric-ad/54375/Moisturization is foundational in AD management; no specific formulation has demonstrated superiority, and excessive bathing may worsen disease via increased transepidermal water loss. Topical corticosteroids and calcineurin inhibitors remain first-line due to strong efficacy data, cost-effectiveneThe New POSEIDON Criteria: The WHY, the WHAT, and the HOW
https://reachmd.com/programs/global-womens-health-academy/new-poseidon-criteria-why-what-and-how/9904/Dr. Sandro Esteves reviews the new POSEIDON criteria & discusses innovative alternatives for clinical management.New Frontiers in the Treatment of DMD Across the Age Spectrum
https://reachmd.com/programs/cme/new-frontiers-in-the-treatment-of-dmd-across-the-age-spectrum/32740/Explore the latest treatment options, age-specific management strategies, and clinical trial data for patients with Duchenne muscular dystrophy (DMD). Through expert-led discussions and real-world patient cases, you’ll gain practical insights to help you confidently navigate today’s ever-evolving trProgress in Breast Cancer Care: Translating SABCS Data Into Practice
https://reachmd.com/programs/cme/progress-in-breast-cancer-care-translating-sabcs-data-into-practice/48989/Learn to integrate the latest data on ADCs in breast cancer into clinical practice, expand treatment options, and apply emerging evidence in real-world care.Quantifying CKD-aP: Tools for Better Care
https://reachmd.com/programs/cme/quantifying-ckd-ap-tools-for-better-care/36295/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
https://reachmd.com/programs/cme/beyond-the-joint-cross-specialty-solutions-for-advancing-tgct-patient-care/36596/Explore TGCT recognition, clinical evidence, treatment strategies, and management of adverse events with CSF1R inhibitors in an interdisciplinary context.Evaluating Patient and Clinician-Reported Responses to Axatilimab in cGVHD
https://reachmd.com/programs/project-oncology/evaluating-patient-and-clinician-reported-responses-to-axatilimab-in-cgvhd/36314/A post-hoc analysis of the AGAVE-201 trial found that symptom improvement and quality-of-life measures in patients with chronic graft versus-host-disease (cGVHD) receiving axatilimab showed meaningful response, even if the patients didn’t meet NIH-based scoring goals. This suggests that clinician anAdvancing Care for Women With Aortic Stenosis: 2-Year Outcomes for Women in the 5-Year SMART Trial
https://reachmd.com/clinical-practice/cardiology/advancing-care-for-women-with-aortic-stenosis-2-year-outcomes-for-women-in-the-5-year-smart-trial/39669/Two-year SMART data show differences in valve performance and hemodynamics that may inform your treatment of women with AS and small annuli.CKD-aP: Beyond the Surface
https://reachmd.com/programs/cme/ckd-ap-beyond-the-surface/36294/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.